Octagon Capital Advisors’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15M | Sell |
7,691,334
-208,666
| -3% | -$407K | 3.29% | 13 |
|
2025
Q1 | $13.9M | Sell |
7,900,000
-1,302,907
| -14% | -$2.29M | 2.69% | 13 |
|
2024
Q4 | $24.5M | Sell |
9,202,907
-2,968,606
| -24% | -$7.9M | 4.03% | 6 |
|
2024
Q3 | $27.9M | Buy |
12,171,513
+11,739,913
| +2,720% | +$26.9M | 4.34% | 8 |
|
2024
Q2 | $1.26M | Sell |
431,600
-943,270
| -69% | -$2.75M | 0.2% | 40 |
|
2024
Q1 | $5M | Buy |
1,374,870
+374,870
| +37% | +$1.36M | 0.6% | 36 |
|
2023
Q4 | $1.51M | Buy |
+1,000,000
| New | +$1.51M | 0.24% | 29 |
|